1. Home
  2. CRVS vs EVLV Comparison

CRVS vs EVLV Comparison

Compare CRVS & EVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

N/A

Current Price

$10.60

Market Cap

843.7M

Sector

Health Care

ML Signal

N/A

Logo Evolv Technologies Holdings Inc.

EVLV

Evolv Technologies Holdings Inc.

N/A

Current Price

$4.55

Market Cap

994.7M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CRVS
EVLV
Founded
2014
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
843.7M
994.7M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
CRVS
EVLV
Price
$10.60
$4.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
★ $31.50
$9.85
AVG Volume (30 Days)
998.8K
★ 2.1M
Earning Date
11-05-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 48.04
41.18
EPS
N/A
★ N/A
Revenue
N/A
★ $145,905,000.00
Revenue This Year
N/A
$25.01
Revenue Next Year
N/A
$20.02
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 40.48
52 Week Low
$6.39
$4.02
52 Week High
$26.95
$7.48

Technical Indicators

Market Signals
Indicator
CRVS
EVLV
Relative Strength Index (RSI) 50.34 47.16
Support Level $9.21 N/A
Resistance Level $10.81 $5.86
Average True Range (ATR) 0.64 0.20
MACD 0.12 0.03
Stochastic Oscillator 73.19 49.32

Price Performance

Historical Comparison
CRVS
EVLV

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc is a security technology company pioneering Artificial Intelligence (AI)-powered screening solutions designed to help create safer environments while maintaining efficient visitor flow and a positive visitor experience. It serves customers across a range of end markets, including education, healthcare, sports, live entertainment, tourist attractions, houses of worship, and industrial workplaces. The company operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

Share on Social Networks: